Multiomic Health
Curated by SignalDeveloper of AI-based multi-omics platform for precision medicine
Overview
Developer of AI-based multi-omics platform for precision medicine. The company is developing machine learning-enhanced systems biology models and composite biomarkers for the development of therapeutics for metabolic syndrome.
Key facts
- Founded
- 2021
- Headquarters
- London, United Kingdom
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 3 products and services
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view